Initial testing of topotecan by the pediatric preclinical testing program-Reference-Cited by-同舟云学术

Initial testing of topotecan by the pediatric preclinical testing program

Published:2009-12-16 Issue:5 Volume:54 Page:707-715
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr. Blood Cancer

Author:

Carol Hernan,Houghton Peter J.,Morton Christopher L.,Kolb E. Anders,Gorlick Richard,Reynolds C. Patrick,Kang Min H.,Maris John M.,Keir Stephen T.,Watkins Amy,Smith Malcolm A.,Lock Richard B.

Funder

National Cancer Institute

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/pbc.22352/fullpdf

Reference48 articles.

1. The development of camptothecin analogs in childhood cancers;Bomgaars;Oncologist,2001

2. Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I;Hsiang;J Biol Chem,1985

3. Therapeutic efficacy of the topoisomerase I inhibitor 7-ethyl-10-(4-[1-piperidino]-1-piperidino)-carbonyloxy-camptothecin against pediatric and adult central nervous system tumor xenografts;Hare;Cancer Chemother Pharmacol,1997

4. Effective schedules of exposure of medulloblastoma and rhabdomyosarcoma xenografts to topotecan correlate with in vitro assays;Pawlik;Clin Cancer Res,1998

5. Efficacy of topoisomerase I inhibitors, topotecan and irinotecan, administered at low dose levels in protracted schedules to mice bearing xenografts of human tumors;Houghton;Cancer Chemother Pharmacol,1995

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current Role of Topoisomerase I Inhibitors for the Treatment of Mesenchymal Malignancies and Their Potential Future Use as Payload of Sarcoma-Specific Antibody-Drug Conjugates;Oncology Research and Treatment;2023-11-28

2. Nucleolar Stress Response via Ribosomal Protein L11 Regulates Topoisomerase Inhibitor Sensitivity of P53-Intact Cancers;International Journal of Molecular Sciences;2022-12-15

3. Novel Therapies for Relapsed and Refractory Neuroblastoma;Children;2018-10-31

4. Topotecan/carboplatin regimen for refractory/recurrent rhabdomyosarcoma in children: Report from the AIEOP Soft Tissue Sarcoma Committee;Tumori Journal;2018-08-22

5. Preclinical Evaluation of Combined Topoisomerase and Proteasome Inhibition Against Pediatric Malignancies;Anticancer Research;2018-07